Evidence map›Paper›PMID 39235855›Full record

ArticleJMIR research protocols2024

Digitizing Survivorship Care Plans Through the POST-Treatment Health Outcomes of Cancer Survivors (POSTHOC) Mobile App: Protocol for a Phase II Randomized Controlled Trial.

Kaitlin H Chung, Shari M Youngblood, Carin L Clingan, Dana C Deighton, Virginia A Jump, Thushini Manuweera, Nicolette M McGeorge, Cynthia L Renn, Paula Y Rosenblatt, Aaron T Winder and 3 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05499663 (Leveraging Technology to Address POST-Treatment Health Outcomes of Cancer Survivors), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05499663 phase1 / phase2completednot on this map

Leveraging Technology to Address POST-Treatment Health Outcomes of Cancer Survivors (POSTHOC-II): A Phase II Survivorship Care Plan Randomized Controlled Trial

TypeinterventionalSponsorUniversity of Maryland, BaltimoreRan2024 to 2025Enrolled51ConditionsSurvivorship, Cancer, Symptoms and SignsArmsPOSTHOC app
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kaitlin H Chung *Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, United States.ORCID 0009-0009-7482-1059
Shari M Youngblood *Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, United States.ORCID 0000-0003-3037-7821
Carin L ClinganDepartment of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, United States.ORCID 0009-0001-7637-344X
Dana C DeightonUniversity of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, United States.ORCID 0000-0002-1362-4387
Virginia A JumpUniversity of Maryland Medical Center, Baltimore, MD, United States.ORCID 0009-0002-4070-0864
Thushini ManuweeraDepartment of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, United States.ORCID 0000-0003-1932-100X
Nicolette M McGeorgeCharles River Analytics, Cambridge, MA, United States.ORCID 0000-0002-6516-2911
Cynthia L RennDepartment of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, United States.ORCID 0000-0001-6764-9347
Paula Y RosenblattUniversity of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, United States.ORCID 0000-0003-1819-1653
Aaron T WinderCharles River Analytics, Cambridge, MA, United States.ORCID 0000-0001-5448-0634
Shijun ZhuDepartment of Organizational Systems and Adult Health, University of Maryland School of Nursing, Baltimore, MD, United States.ORCID 0009-0007-7365-7256
Ian R KlecknerDepartment of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, United States.ORCID 0000-0002-9828-9986
Amber S KlecknerDepartment of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, United States.ORCID 0000-0002-5088-1139

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
The Nathan Schnaper Intern Program in Translational Cancer ResearchR25CA186872 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI BRET A HASSEL, Ian Robert Kleckner · 2015 to 2026
$3.0M
TOPIC 385: POST-Treatment Health Outcomes of Cancer (POSTHOC)75N91021C00019 · NCI · CHARLES RIVER ANALYTICS, INC. · PI WINDER, AARON · 2021 to 2021
$1.5M
The Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy, Inflammation, and Interoceptive Brain CircuitryK07CA221931 · NCI · UNIVERSITY OF ROCHESTER · PI KLECKNER, IAN ROBERT · 2018 to 2022
$795k
NCI NIH HHS 75N91021C00019NCI NIH HHS K07 CA221931NCI NIH HHS P30 CA134274NCI NIH HHS R25 CA186872
6 · The paper itself

Abstract

backgroundSurvivorship care plans (SCPs) are provided at the completion of cancer treatment to aid in the transition from active treatment to long-term survivorship. They describe the details of a patient's diagnosis and treatment and offer recommendations for follow-up appointments, referrals, and healthy behaviors. The plans are currently paper-based and become outdated as soon as a patient's health status changes. There is a need to digitize these plans to improve their accessibility, modifiability, and longevity. With current technology, SCPs can be linked to mobile devices and activity trackers so that patients can track health behaviors and compare them to their clinical goals, taking charge of their own health.

objectiveA mobile app, POSTHOC (POST-Treatment Health Outcomes of Cancer Survivors), that digitizes the SCP was developed, with goals of integrating it with wearable technologies and electronic medical records. Herein, we are conducting a randomized controlled trial that evaluates the POSTHOC app versus the traditional SCP on total symptom burden in the early posttreatment period.

methodsWe will recruit 54 patients who have recently completed curative therapy for cancer (any type) in person and remotely. They will be randomized 2:1, POSTHOC:usual care (unblinded). Those randomized to the POSTHOC group will receive their SCP via the app and will choose to focus on nutrition or exercise for the duration of the study based on their individual plan and personal preferences. Those randomized to the control group will get a paper-based plan. At baseline, 6 weeks, and 12 weeks, we will evaluate patient-reported outcomes, including total symptom burden (web-based questionnaire), diet (24-hour Automated Self-Administered [ASA24]), and physical activity (Fitbit Charge 6 [Google LLC]). We will also collect quantitative and qualitative feedback on the usability of the app from those in the POSTHOC arm to improve the app for future implementation studies, with a specific focus on patient-provider communication. For feasibility, we will calculate the percentage of patients who used the POSTHOC app at least 3 times per week. We will use linear mixed models to evaluate the effects of the POSTHOC app versus those of usual care on other outcomes at weeks 6 and 12.

resultsThis trial is open to accrual in the University of Maryland Medical System as of March 2024, and as of July 3, 2024, a total of 20 participants have consented.

conclusionsThis study is among the first to digitize the SCP in a mobile app and test the effects of a mobile health-delivered behavioral health intervention on symptom burden in cancer survivors. Our results will provide evidence about the effects of health self-management on symptoms. This knowledge will be integral to larger randomized controlled studies, integration with the electronic medical record, and nationwide implementation.

trial registrationClinicalTrials.gov NCT05499663; https://clinicaltrials.gov/ct2/show/NCT05499663. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/59222.

Indexed as

Cancer SurvivorsMobile ApplicationsAdultClinical Trials, Phase II as TopicFemaleHumansMaleMiddle AgedNeoplasmsPatient Care PlanningRandomized Controlled Trials as TopicSurvivorshipclinical trialmHealthmobile healthmobile phoneoncologyposttreatmentsymptoms

Identifiers

PMID39235855
PMCPMC11413545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.